The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by D’Orazio, S. E. F.
Right arrow Articles by Starnbach, M. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by D’Orazio, S. E. F.
Right arrow Articles by Starnbach, M. N.
The Journal of Immunology, 2003, 171: 291-298.
Copyright © 2003 by The American Association of Immunologists

Class Ia MHC-Deficient BALB/c Mice Generate CD8+ T Cell-Mediated Protective Immunity Against Listeria monocytogenes Infection1

Sarah E. F. D’Orazio*, Dina G. Halme{dagger}, Hidde L. Ploegh{dagger} and Michael N. Starnbach2,*

Departments of * Microbiology and Molecular Genetics and {dagger} Pathology, Harvard Medical School, Boston, MA 02115

CD8+ T cells are required for protective immunity against intracellular pathogens such as Listeria monocytogenes. In this study, we used class Ia MHC-deficient mice, which have a severe reduction in circulating CD8+ T cells, to determine the protective capacity of class Ib MHC-restricted T cells during L. monocytogenes infection. The Kb-/-Db-/- mutation was backcrossed onto a C.B10 (BALB/c congenic at H-2 locus with C57BL/10) background, because BALB/c mice are more susceptible to Listeria infection than other commonly studied mouse strains such as C57BL/6. C.B10 Kb-/-Db-/- mice immunized with a sublethal dose of L. monocytogenes were fully protected against a subsequent lethal infection. Adoptive transfer of Listeria-immune splenocyte subsets into naive Kb-/-Db-/- mice indicated that CD8+ T cells were the major component of this protective immune response. A CD8+ T cell line isolated from the spleen of a Listeria-infected class Ia MHC-deficient mouse was shown to specifically recognize Listeria-infected cells in vitro, as determined by IFN-{gamma} secretion and cytotoxicity assays. Adoptive transfer of this T cell line alone resulted in significant protection against L. monocytogenes challenge. These results suggest that even a limited number of class Ib MHC-restricted T cells are sufficient to generate the rapid recall response required for protection against secondary infection with L. monocytogenes.




This article has been cited by other articles:


Home page
J. Immunol.Home page
A. Tvinnereim and B. Wizel
CD8+ T Cell Protective Immunity against Chlamydia pneumoniae Includes an H2-M3-Restricted Response That Is Largely CD4+ T Cell-Independent
J. Immunol., September 15, 2007; 179(6): 3947 - 3957.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. T. Chow, S. Dhanji, J. Cross, P. Johnson, and H.-S. Teh
H2-M3-Restricted T Cells Participate in the Priming of Antigen-Specific CD4+ T Cells
J. Immunol., October 15, 2006; 177(8): 5098 - 5104.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
S. E.F. D'Orazio, C. A. Shaw, and M. N. Starnbach
H2-M3-restricted CD8+ T cells are not required for MHC class Ib-restricted immunity against Listeria monocytogenes
J. Exp. Med., February 21, 2006; 203(2): 383 - 391.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
H. Xu, T. Chun, H.-J. Choi, B. Wang, and C.-R. Wang
Impaired response to Listeria in H2-M3-deficient mice reveals a nonredundant role of MHC class Ib-specific T cells in host defense
J. Exp. Med., February 21, 2006; 203(2): 449 - 459.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.